Special Issue: Pharmacy Benefits

A Gray Area for Reimbursement: Medical Foods for Non–Inborn Errors of Metabolism

July 10, 2018


Most non–inborn errors of metabolism (non-IEM) medical foods (MFs) do not meet the regulatory MF definition and lack scientific evidence for safety and efficacy. Non-IEM MFs are not yet ready for reimbursement by public insurers.

5-ASA to Sulfasalazine Drug Switch Program in Patients With Ulcerative Colitis

July 11, 2018


A 5-aminosalicylic acid (5-ASA) drug switch program switching from 5-ASA to sulfasalazine was instituted for insured patients with ulcerative colitis. Unanticipated barriers limited the number of patients who switched, but significant cost savings were still obtained.

Treatment Patterns Among Adults With ADHD Receiving Long-Acting Therapy

July 13, 2018


Adults with attention-deficit/hyperactivity disorder (ADHD) who received long-acting combination therapy had significantly lower adherence and persistence compared with those who received long-acting monotherapy.